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Abstract: Polymeric foams seem to have
potential for use in many research areas such
as cell seeding and macromolecule or drug
loading. Three factors were studied to
evaluate the efficiency of foams as drug
carrier and releasing agents. Effect of
polymeric properties was examined by using
two types of polymers (PHBV 7 and PHBV
22) differing only in their valerate
(copolymer) content. The other factor
studied was the effect of loading extent on
release kinetics and rate. The results showed
an unexpected inverse proportionality
between drug loading and release rate. They,
however, were in accordance with foam
physical properties such as porosity, which

Introduction
Controlled drug release systems are being used with
increased frequency in the treatment of many diseases
(1,2). Cases where long term delivery, and/or minimal
fluctuation of plasma concentration of the drug are
needed are when these systems mainly used. This is
especially important in application of biotechnologically
obtained oligomers and macromolecular bioactive agents
(DNA, plasmids, enzymes, vaccines) to the tissues. Here,
the protection of the bioactive agent from the
environment and release controlling effect provided by
the carrier system gains more importance. Since
macromolecular structures have difficulty in diffusing
through membranes, systems involving them release their
contents either by the degradation of the carrier or by
employing an open celled carrier foams or both. In
addition foams carrying antibiotics could be very
important in tissue engineering where foams are
impregnated with the respective cell of the tissue aimed.
Presence of an antibiotic would drastically decrease the
risk of infection and thus failure. In a previous study poly
(l-lactic acid) foams were prepared to study cell seeding
and controlled release performance by using two model
compounds, bromothymol blue and sulforhodamine B

dominate the control of release from the
foam. When the concentration of the
polymer solution increased the density of the
resulting foam increased leading to a less
porous structure and to a slower release
rate. In all cases, complete drug release took
place within a very short time period most
probably due to the high water solubility and
low molecular weight of the drug molecule. It
is expected that it will be possible to achieve
a longer term release with larger bioactive
agents like enzymes, plasmids or antibodies.
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(3). Poly (d,l-lactide-co-glycolide) foams were also
prepared by Hsu et al (1996) and they investigated the
release of isoniazid from these systems (4,5). In the
present study preparation of a controlled release system
using another biodegradable and biocompatible polymer,
poly(3-hydroxybutyrate-co-3-hydroxyvalerate), PHBV,
for the release of an antibacterial agent, tetracycline
(6,7,8) was aimed. The densities and drug release
behaviors of the foams were studied and their
morphologic properties were investigated by scanning
electron microscopy.
Material and Methods
Materials
Poly (3-hydroxybutyrate-co-3-hydroxyvalerate) with
hydroxyvalerate contents of 7 and 22 percent (molar) and
with molecular weights ranging between 400,000750,000 D were purchased from Aldrich Chem. Co. (USA).
Methods
Preparation of PHBV Foams
Foams were prepared by lyophilization of polymer
solutions after freezing in order to prevent the formation
9

Preparation of PHBV Foams and Investigation of Their Potential For Drug Release

of a compressed, dense foam or macroporous membrane.
PHBV (ca. 1 g) was dissolved in chloroform (9 ml) and
then acetic acid (18 ml) was added. This solution was
then frozen at -28˚C in an appropriate standard petri
plate and freeze-dried at RT. After obtaining empty foams
with this process, samples (ca. 2 X 2 cm2 ) were cut and
submerged in tetracycline.HCl (TC.HCl) solutions the
concentration of which was varied according to the
loading ratio required (Table 1). By applying vacuum (ca.1
mm Hg) and then rapidly releasing it by letting in the air,
all the drug was forced into the foams which were then
dried thus leading to 100% loading.
Release Method
Drug release was studied in a static release sytem.
Samples (ca. 0.5 X 0.5 cm2 ) were introduced to
phosphate buffer saline (250 ml, 0.1 M, pH 7.4) which
was continuously agitated in a shaking water bath at
37˚C. Samples (3 ml) were removed at different time
intervals, tetracycline content was detected with UV
spectrophotometer by measuring the absorbance at 360
nm and then returned to the release media. Release
studies were carried out in triplicates.
Determination of Foam Density

Polymer
Type

F1
F2
F3
F4

PHBV
PHBV
PHBV
PHBV
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7
7
7
22

For the calculation of the foam density the following
equations were used:
ww1 = w1 - w0

[1]

ww2 = w2 - wf - w0

[2]

wr = ww1 - ww2

[3]

Vw = wr + (w3 - wf)

[4]

Vw = Vf

[5]

Df =wf / Vf

[6]

where,
wr : weight of water displaced by foam
Vw : volume of displaced water which is equal to its
weight
Results and Discussion
Foam Density

Densities of the PHBV foams were determined with a
pycnometer. Pycnometer was weighed when empty (w0)
and when it was completely filled with water (w1). Then
a previously weighed foam (wf) was put into the
pycnometer which was then topped with distilled water
and weighed again (w2). However, during this process
some water was absorbed by the hydrophobic foam
because of its porous structure and the capillary action,
and this value was used in correcting the data. The foam
was, therefore, weighed again after removal from the
pycnometer (w3). All these data were used to calculate the

Sample
Code

volume of the foam (Vf), and eventually the density of the
foam (Df).

By controlling the shape and the solvent volume (the
size of the container), it is possible to produce foam
structures with desired density and thickness (Table 1).
The type of the polymer used also had its contribution
(compare F2 and F4). It thus appears that foams with less
void can be obtained by increasing the concentration of
the polymer in the solution. The polymer type influences
viscosity due to their crystallinities and solubilities in a
particular solvent being different, the chain extend more
or less leading to low or high densities.

Solvent Ratio
Chloroform: Acetic
Acid (v/v)

Concentration
of Polymer
(g/ml)

Density
(mg/ml)

Loading
Ratios
Drug: Polymer

1:2
1:2
1:2
1:2

0.02
0.04
0.06
0.04

33.8
52.7
67.1
41.4

1:5
1:5, 1:4, 1:3
1:5

Table 1.

Effect of Polymer Type and
Polymer Solution Composition
on Foam Density.
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shows, the loading has an inverse effect on the rate of
release. When the amount of drug loaded to foams
increased, the release rate decreased. Although it appears
to be contrary to the general expectation for release of a
drug from a polymer matrix or capsule, the situation here
is very different. The structure from which release is
taking place is an open celled foam (Figure 3a). As can be
seen from the figure, there is no diffusion restriction and
the drug is loaded to a very high extent and is removed
without changing the foam morphology to a detectable
level (Figure 3b and 3c). When there is more drug
loading, the interaction of drug crystals with the
dissolution medium is decreased due to decreased surface
to volume ratio of the drug, and due to occlusion of the
pores by the drug crystals leading to a lower release rate
when the drug content is high. This becomes apparent
when the released amount of drug (not its ratio to the
input) is plotted (not presented). There it is seen that
during the first 5 hours the amounts released are the
same even though the loadings are different, proving the
point made here.

Release Results
Release of TC.HCl from PHBV7 and PHBV22 foams
are compared in Figure 1. When release from equal initial
polymer concentration materials with different polymer
types are compared, release of drug initially appears to be
at similar high rates. This rate, however, decreases
substantially for PHBV 7 at 1 h while it is maintained for
another 3 h with PHBV 22. When the data is plotted to
determine obedience either to diffusion controlled release
(amount released vs square root of time) or the first
order kinetics (natural logarithm of amount released vs
time) the diffusion controlled release appear to be obeyed
more. However, as the drug molecule is too small (MW:
481) in comparison to the size of the pores of the carrier,
diffusion is not a very much release controlling factor
here. Rather the drug release is thought to be mostly
controlled by the solubility of the drug in the water
present in pores of the foam structure and by convection
through pores after being dissolved. So the surface to
volume ratio of the drug crystals gains importance
because it is directly proportional to the dissolution as
well as the amount of drug that has been stored in the
structure as they would affect the solubility of the drug.

Release data presented in Figure 4 reveals that foam
preparation from the more concentrated polymer
solution leads to a foam with higher density (67.1 mg/ml
vs 52.7 mg/ml, Table 1) and also to a foam from which
the release rate is lower. Release kinetics, however, do
not change from what was observed with F2 and F4.

In order to evaluate the effect of loading on release,
three different drug loading ratios (drug: polymer weight
ratios of 1:3, 1:4, 1:5) were used in the study. Figure 2
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Figure 2.

Effect of Amount of Drug
Loading on Release From
PHBV Foams

Figure 3a.

SEM of PHBV 7 Foams
Prepared From an Inıtial 6%
Polymer Solution (F3). a.
Unloaded,

Figure 3b.

SEM of PHBV 7 Foams
Prepared From an Inıtial 6%
Polymer Solution (F3) b.
Tetracycline loaded.
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Figure 3c.

SEM of PHBV 7 Foams
Prepared From an Inıtial 6%
Polymer Solution (F3) c. After
release of tetracycline.

Figure 4.

Effect
of
Polymer
Concentration on Release
From PHBV 7 Foams.
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Conclusion
As the data presented above reveals, open celled
foams have very limited control on release of low
molecular weight substances. The parameters that have
control on release rate are the foam density, drug loading
and to very small extent, the polymer type. Such opencelled structures might, however, be very effective

carriers for controlled release of larger molecules such as
proteins and polynucleotides. With the current
enthusiasm about the biotechnological production of
bioactive species prevailing we feel that these foams are
going to be quite useful in nucleic acid and vaccine
delivery.
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